Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01741467 · ClinicalTrials.gov registry record · NA

The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes

A NA study of PreDiabetes and Impaired Glucose Tolerance, sponsored by Walter Reed National Military Medical Center.

Completed
Registry status
NA
Development phase
110
Enrollment target
1
Study location

NCT01741467: Completed NA study of PreDiabetes and Impaired Glucose Tolerance, sponsored by Walter Reed National Military Medical Center.

NCT01741467 is a NA study of PreDiabetes and Impaired Glucose Tolerance that has completed, run by Walter Reed National Military Medical Center. The registered enrollment target is 110 participants, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01741467, a NA study of PreDiabetes and Impaired Glucose Tolerance, has completed, sponsored by Walter Reed National Military Medical Center.

COMPLETED
Registry status
NA
Development phase
110 participants
Enrollment target
1
Study location

Study Summary

This study will investigate whether real-time continuous glucose monitoring can be used as a tool for behavior change in people with pre-diabetes.

Primary Outcome

Changes in A1c and fasting blood glucose over time and between the intervention and control groups.

Interventions

  • BEHAVIORAL RT-CGM

Study Locations (1)

Maryland

  • Walter Reed National Military Medical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 110 participants
Start Date 2012-05
Est. Completion 2016-08
Phase NA

What the finished NCT01741467 record still lists

NCT01741467 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 701-participant average among 149 other PreDiabetes trials with a reported enrollment target (84% lower).

The record links to 2 conditions, with PreDiabetes appearing as the primary indexed condition, and to 1 intervention - of which RT-CGM is the first listed.

NCT01741467 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT01741467 about?

NCT01741467 is a clinical study titled "The Effect of Real Time Continuous Glucose Monitoring in Subjects With Pre-diabetes". This study will investigate whether real-time continuous glucose monitoring can be used as a tool for behavior change in people with pre-diabetes.

What is the current status of trial NCT01741467?

This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2012-05. Estimated completion is 2016-08.

What conditions does trial NCT01741467 study?

This clinical trial studies the following conditions: PreDiabetes, Impaired Glucose Tolerance.

What interventions are being tested in trial NCT01741467?

The interventions under investigation include: RT-CGM (BEHAVIORAL).

Who is sponsoring clinical trial NCT01741467?

This trial is sponsored by Walter Reed National Military Medical Center, which has 48 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01741467 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for PreDiabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01741467's enrollment target sits among peer trials

110 55th of 149 higher than 94 of 149 other PreDiabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other PreDiabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01530373 · 110 participants · Phase 2

    Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients

  • NCT02379377 · 110 participants · Phase 1

    18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant

  • NCT02411773 · 110 participants · Phase 1

    Sympatholysis in Chronic Kidney Disease

  • NCT03190941 · 110 participants · Phase 1

    Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01741467, the US trial registry maintained by the National Library of Medicine. NCT01741467 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.